vs
FRESH DEL MONTE PRODUCE INC（FDP）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
FRESH DEL MONTE PRODUCE INC的季度营收约是Revvity的1.3倍（$1.0B vs $772.1M），Revvity净利率更高（12.7% vs 3.2%，领先9.6%），Revvity同比增速更快（5.9% vs 0.6%），Revvity自由现金流更多（$161.8M vs $-17.2M），过去两年Revvity的营收复合增速更高（9.0% vs -4.1%）
鲜德尔蒙农产品公司是全球领先的垂直一体化生鲜及鲜切果蔬、加工果蔬生产、分销及营销企业，注册地位于开曼群岛乔治敦，美国行政总部设在佛罗里达州科勒尔盖布尔斯塞维利亚大道241号。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
FDP vs RVTY — 直观对比
营收规模更大
FDP
是对方的1.3倍
$772.1M
营收增速更快
RVTY
高出5.2%
0.6%
净利率更高
RVTY
高出9.6%
3.2%
自由现金流更多
RVTY
多$179.0M
$-17.2M
两年增速更快
RVTY
近两年复合增速
-4.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $772.1M |
| 净利润 | $32.3M | $98.4M |
| 毛利率 | 10.4% | — |
| 营业利润率 | 4.5% | 14.5% |
| 净利率 | 3.2% | 12.7% |
| 营收同比 | 0.6% | 5.9% |
| 净利润同比 | 59.1% | 3.9% |
| 每股收益（稀释后） | $0.67 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FDPRVTY
| Q4 25 | $1.0B | $772.1M | ||
| Q3 25 | $1.0B | $698.9M | ||
| Q2 25 | $1.2B | $720.3M | ||
| Q1 25 | $1.1B | $664.8M | ||
| Q4 24 | $1.0B | $729.4M | ||
| Q3 24 | $1.0B | $684.0M | ||
| Q2 24 | $1.1B | $691.7M | ||
| Q1 24 | $1.1B | $649.9M |
净利润FDPRVTY
| Q4 25 | $32.3M | $98.4M | ||
| Q3 25 | $-29.1M | $46.7M | ||
| Q2 25 | $56.8M | $53.9M | ||
| Q1 25 | $31.1M | $42.2M | ||
| Q4 24 | $20.3M | $94.6M | ||
| Q3 24 | $42.1M | $94.4M | ||
| Q2 24 | $53.6M | $55.4M | ||
| Q1 24 | $26.1M | $26.0M |
毛利率FDPRVTY
| Q4 25 | 10.4% | — | ||
| Q3 25 | 7.9% | 53.6% | ||
| Q2 25 | 10.2% | 54.5% | ||
| Q1 25 | 8.4% | 56.5% | ||
| Q4 24 | 6.8% | — | ||
| Q3 24 | 9.2% | 56.3% | ||
| Q2 24 | 9.9% | 55.7% | ||
| Q1 24 | 7.4% | 54.6% |
营业利润率FDPRVTY
| Q4 25 | 4.5% | 14.5% | ||
| Q3 25 | -2.1% | 11.7% | ||
| Q2 25 | 5.8% | 12.6% | ||
| Q1 25 | 4.1% | 10.9% | ||
| Q4 24 | 3.0% | 16.3% | ||
| Q3 24 | 5.3% | 14.3% | ||
| Q2 24 | 6.0% | 12.4% | ||
| Q1 24 | 4.0% | 6.8% |
净利率FDPRVTY
| Q4 25 | 3.2% | 12.7% | ||
| Q3 25 | -2.8% | 6.7% | ||
| Q2 25 | 4.8% | 7.5% | ||
| Q1 25 | 2.8% | 6.4% | ||
| Q4 24 | 2.0% | 13.0% | ||
| Q3 24 | 4.1% | 13.8% | ||
| Q2 24 | 4.7% | 8.0% | ||
| Q1 24 | 2.4% | 4.0% |
每股收益（稀释后）FDPRVTY
| Q4 25 | $0.67 | $0.86 | ||
| Q3 25 | $-0.61 | $0.40 | ||
| Q2 25 | $1.18 | $0.46 | ||
| Q1 25 | $0.64 | $0.35 | ||
| Q4 24 | $0.41 | $0.77 | ||
| Q3 24 | $0.88 | $0.77 | ||
| Q2 24 | $1.12 | $0.45 | ||
| Q1 24 | $0.55 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $35.7M | $919.9M |
| 总债务越低越好 | $176.2M | — |
| 股东权益账面价值 | $2.0B | $7.3B |
| 总资产 | $3.1B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.09× | — |
8季度趋势，按日历期对齐
现金及短期投资FDPRVTY
| Q4 25 | $35.7M | $919.9M | ||
| Q3 25 | $97.2M | $931.4M | ||
| Q2 25 | $85.5M | $991.8M | ||
| Q1 25 | $34.4M | $1.1B | ||
| Q4 24 | $32.6M | $1.2B | ||
| Q3 24 | $50.8M | $1.2B | ||
| Q2 24 | $37.8M | $2.0B | ||
| Q1 24 | $42.2M | $1.7B |
总债务FDPRVTY
| Q4 25 | $176.2M | — | ||
| Q3 25 | $176.7M | — | ||
| Q2 25 | $205.2M | — | ||
| Q1 25 | $237.4M | — | ||
| Q4 24 | $248.9M | — | ||
| Q3 24 | $274.8M | — | ||
| Q2 24 | $290.4M | — | ||
| Q1 24 | $405.8M | — |
股东权益FDPRVTY
| Q4 25 | $2.0B | $7.3B | ||
| Q3 25 | $2.0B | $7.4B | ||
| Q2 25 | $2.1B | $7.6B | ||
| Q1 25 | $2.0B | $7.6B | ||
| Q4 24 | $2.0B | $7.7B | ||
| Q3 24 | $2.0B | $7.9B | ||
| Q2 24 | $2.0B | $7.9B | ||
| Q1 24 | $1.9B | $7.8B |
总资产FDPRVTY
| Q4 25 | $3.1B | $12.2B | ||
| Q3 25 | $3.1B | $12.1B | ||
| Q2 25 | $3.2B | $12.4B | ||
| Q1 25 | $3.2B | $12.4B | ||
| Q4 24 | $3.1B | $12.4B | ||
| Q3 24 | $3.2B | $12.8B | ||
| Q2 24 | $3.1B | $13.4B | ||
| Q1 24 | $3.2B | $13.4B |
负债/权益比FDPRVTY
| Q4 25 | 0.09× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.10× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.9M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-17.2M | $161.8M |
| 自由现金流率自由现金流/营收 | -1.7% | 21.0% |
| 资本支出强度资本支出/营收 | 2.8% | 2.6% |
| 现金转化率经营现金流/净利润 | 0.34× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $181.3M | $509.4M |
8季度趋势，按日历期对齐
经营现金流FDPRVTY
| Q4 25 | $10.9M | $182.0M | ||
| Q3 25 | $75.0M | $138.5M | ||
| Q2 25 | $113.1M | $134.3M | ||
| Q1 25 | $46.1M | $128.2M | ||
| Q4 24 | $-4.7M | $174.2M | ||
| Q3 24 | $43.5M | $147.9M | ||
| Q2 24 | $125.0M | $158.6M | ||
| Q1 24 | $18.7M | $147.6M |
自由现金流FDPRVTY
| Q4 25 | $-17.2M | $161.8M | ||
| Q3 25 | $60.9M | $120.0M | ||
| Q2 25 | $101.5M | $115.5M | ||
| Q1 25 | $36.1M | $112.2M | ||
| Q4 24 | $-22.3M | $149.8M | ||
| Q3 24 | $30.1M | $125.6M | ||
| Q2 24 | $117.0M | $136.6M | ||
| Q1 24 | $6.0M | $129.7M |
自由现金流率FDPRVTY
| Q4 25 | -1.7% | 21.0% | ||
| Q3 25 | 6.0% | 17.2% | ||
| Q2 25 | 8.6% | 16.0% | ||
| Q1 25 | 3.3% | 16.9% | ||
| Q4 24 | -2.2% | 20.5% | ||
| Q3 24 | 3.0% | 18.4% | ||
| Q2 24 | 10.3% | 19.7% | ||
| Q1 24 | 0.5% | 20.0% |
资本支出强度FDPRVTY
| Q4 25 | 2.8% | 2.6% | ||
| Q3 25 | 1.4% | 2.6% | ||
| Q2 25 | 1.0% | 2.6% | ||
| Q1 25 | 0.9% | 2.4% | ||
| Q4 24 | 1.7% | 3.4% | ||
| Q3 24 | 1.3% | 3.3% | ||
| Q2 24 | 0.7% | 3.2% | ||
| Q1 24 | 1.1% | 2.7% |
现金转化率FDPRVTY
| Q4 25 | 0.34× | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | 1.99× | 2.49× | ||
| Q1 25 | 1.48× | 3.03× | ||
| Q4 24 | -0.23× | 1.84× | ||
| Q3 24 | 1.03× | 1.57× | ||
| Q2 24 | 2.33× | 2.87× | ||
| Q1 24 | 0.72× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FDP
| Other | $482.7M | 47% |
| Gold Pineapples | $184.9M | 18% |
| Fresh Cut Fruit | $126.4M | 12% |
| Fresh Cut Vegetables | $69.3M | 7% |
| Avocados | $66.9M | 7% |
| Other Fruit Productsand Services | $26.1M | 3% |
| Non Tropical Fruit | $23.0M | 2% |
| Melons | $20.6M | 2% |
| Vegetables | $19.6M | 2% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
